+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tizanidine"

From
Quadriplegia Treatment Market Report 2025 - Product Thumbnail Image

Quadriplegia Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Muscle Spasticity Market Report 2025 - Product Thumbnail Image

Muscle Spasticity Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Muscle Relaxant Drugs Market Report 2025 - Product Thumbnail Image

Muscle Relaxant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Motor Neuron Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Motor Neuron Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 450 Pages
  • Global
From
ZANAFLEX Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZANAFLEX Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Tizanidine is a centrally-acting muscle relaxant used to treat spasticity, a condition characterized by muscle stiffness and spasms. It is a short-acting drug, meaning it is taken as needed to relieve spasticity symptoms. Tizanidine works by blocking nerve impulses that cause muscles to contract. It is available in both oral and intramuscular forms. Tizanidine is used to treat a variety of conditions, including multiple sclerosis, spinal cord injury, cerebral palsy, and stroke. It is also used to treat muscle spasms caused by certain medications, such as baclofen and dantrolene. It is generally well-tolerated, with few side effects. The tizanidine market is a small but growing segment of the central nervous system drugs market. It is used to treat a variety of conditions, and is generally well-tolerated with few side effects. As such, it is becoming increasingly popular as a treatment option for spasticity. Some companies in the tizanidine market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more